
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
How many carbonic anhydrase inhibition mechanisms exist?
Claudiu T. Supuran
Journal of Enzyme Inhibition and Medicinal Chemistry (2015) Vol. 31, Iss. 3, pp. 345-360
Open Access | Times Cited: 676
Claudiu T. Supuran
Journal of Enzyme Inhibition and Medicinal Chemistry (2015) Vol. 31, Iss. 3, pp. 345-360
Open Access | Times Cited: 676
Showing 1-25 of 676 citing articles:
Structure and function of carbonic anhydrases
Claudiu T. Supuran
Biochemical Journal (2016) Vol. 473, Iss. 14, pp. 2023-2032
Closed Access | Times Cited: 784
Claudiu T. Supuran
Biochemical Journal (2016) Vol. 473, Iss. 14, pp. 2023-2032
Closed Access | Times Cited: 784
Advances in structure-based drug discovery of carbonic anhydrase inhibitors
Claudiu T. Supuran
Expert Opinion on Drug Discovery (2016) Vol. 12, Iss. 1, pp. 61-88
Closed Access | Times Cited: 398
Claudiu T. Supuran
Expert Opinion on Drug Discovery (2016) Vol. 12, Iss. 1, pp. 61-88
Closed Access | Times Cited: 398
Inhibition of carbonic anhydrase IX targets primary tumors, metastases, and cancer stem cells: Three for the price of one
Claudiu T. Supuran, Vincenzo Alterio, Anna Di Fiore, et al.
Medicinal Research Reviews (2018) Vol. 38, Iss. 6, pp. 1799-1836
Open Access | Times Cited: 234
Claudiu T. Supuran, Vincenzo Alterio, Anna Di Fiore, et al.
Medicinal Research Reviews (2018) Vol. 38, Iss. 6, pp. 1799-1836
Open Access | Times Cited: 234
Carbonic Anhydrases: Role in pH Control and Cancer
Mam Y. Mboge, Brian P. Mahon, Robert McKenna, et al.
Metabolites (2018) Vol. 8, Iss. 1, pp. 19-19
Open Access | Times Cited: 231
Mam Y. Mboge, Brian P. Mahon, Robert McKenna, et al.
Metabolites (2018) Vol. 8, Iss. 1, pp. 19-19
Open Access | Times Cited: 231
Carbonic Anhydrase Inhibition and the Management of Hypoxic Tumors
Claudiu T. Supuran
Metabolites (2017) Vol. 7, Iss. 3, pp. 48-48
Open Access | Times Cited: 218
Claudiu T. Supuran
Metabolites (2017) Vol. 7, Iss. 3, pp. 48-48
Open Access | Times Cited: 218
Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors
Claudiu T. Supuran
Expert Opinion on Investigational Drugs (2018) Vol. 27, Iss. 12, pp. 963-970
Closed Access | Times Cited: 217
Claudiu T. Supuran
Expert Opinion on Investigational Drugs (2018) Vol. 27, Iss. 12, pp. 963-970
Closed Access | Times Cited: 217
Carbonic Anhydrase Activators
Claudiu T. Supuran
Future Medicinal Chemistry (2018) Vol. 10, Iss. 5, pp. 561-573
Closed Access | Times Cited: 214
Claudiu T. Supuran
Future Medicinal Chemistry (2018) Vol. 10, Iss. 5, pp. 561-573
Closed Access | Times Cited: 214
Benzothiazole derivatives as anticancer agents
Ali Irfan, Fozia Batool, Syeda Andleeb Zahra Naqvi, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2019) Vol. 35, Iss. 1, pp. 265-279
Open Access | Times Cited: 205
Ali Irfan, Fozia Batool, Syeda Andleeb Zahra Naqvi, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2019) Vol. 35, Iss. 1, pp. 265-279
Open Access | Times Cited: 205
An Overview of the Bacterial Carbonic Anhydrases
Claudiu T. Supuran, Clemente Capasso
Metabolites (2017) Vol. 7, Iss. 4, pp. 56-56
Open Access | Times Cited: 202
Claudiu T. Supuran, Clemente Capasso
Metabolites (2017) Vol. 7, Iss. 4, pp. 56-56
Open Access | Times Cited: 202
Carbonic Anhydrases and Metabolism
Claudiu T. Supuran
Metabolites (2018) Vol. 8, Iss. 2, pp. 25-25
Open Access | Times Cited: 183
Claudiu T. Supuran
Metabolites (2018) Vol. 8, Iss. 2, pp. 25-25
Open Access | Times Cited: 183
Carbonic anhydrase inhibitors as antitumor/antimetastatic agents: a patent review (2008–2018)
Alessio Nocentini, Claudiu T. Supuran
Expert Opinion on Therapeutic Patents (2018) Vol. 28, Iss. 10, pp. 729-740
Closed Access | Times Cited: 182
Alessio Nocentini, Claudiu T. Supuran
Expert Opinion on Therapeutic Patents (2018) Vol. 28, Iss. 10, pp. 729-740
Closed Access | Times Cited: 182
Small molecule selenium-containing compounds: Recent development and therapeutic applications
Hongyan Chuai, San‐Qi Zhang, Huanrong Bai, et al.
European Journal of Medicinal Chemistry (2021) Vol. 223, pp. 113621-113621
Closed Access | Times Cited: 166
Hongyan Chuai, San‐Qi Zhang, Huanrong Bai, et al.
European Journal of Medicinal Chemistry (2021) Vol. 223, pp. 113621-113621
Closed Access | Times Cited: 166
Carbonic anhydrase inhibitors and their potential in a range of therapeutic areas
Claudiu T. Supuran
Expert Opinion on Therapeutic Patents (2018) Vol. 28, Iss. 10, pp. 709-712
Open Access | Times Cited: 163
Claudiu T. Supuran
Expert Opinion on Therapeutic Patents (2018) Vol. 28, Iss. 10, pp. 709-712
Open Access | Times Cited: 163
Advances in the structural annotation of human carbonic anhydrases and impact on future drug discovery
Alessio Nocentini, Claudiu T. Supuran
Expert Opinion on Drug Discovery (2019) Vol. 14, Iss. 11, pp. 1175-1197
Closed Access | Times Cited: 147
Alessio Nocentini, Claudiu T. Supuran
Expert Opinion on Drug Discovery (2019) Vol. 14, Iss. 11, pp. 1175-1197
Closed Access | Times Cited: 147
Carbonic Anhydrase Inhibitors Targeting Metabolism and Tumor Microenvironment
Andrea Angeli, Fabrizio Carta, Alessio Nocentini, et al.
Metabolites (2020) Vol. 10, Iss. 10, pp. 412-412
Open Access | Times Cited: 141
Andrea Angeli, Fabrizio Carta, Alessio Nocentini, et al.
Metabolites (2020) Vol. 10, Iss. 10, pp. 412-412
Open Access | Times Cited: 141
Reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydrase
Alessio Nocentini, Andrea Angeli, Fabrizio Carta, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2021) Vol. 36, Iss. 1, pp. 561-580
Open Access | Times Cited: 104
Alessio Nocentini, Andrea Angeli, Fabrizio Carta, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2021) Vol. 36, Iss. 1, pp. 561-580
Open Access | Times Cited: 104
Exploration of 1,2,3-triazole linked benzenesulfonamide derivatives as isoform selective inhibitors of human carbonic anhydrase
Chnar Kakakhan, Cüneyt Türkeş, Özcan Güleç, et al.
Bioorganic & Medicinal Chemistry (2022) Vol. 77, pp. 117111-117111
Closed Access | Times Cited: 81
Chnar Kakakhan, Cüneyt Türkeş, Özcan Güleç, et al.
Bioorganic & Medicinal Chemistry (2022) Vol. 77, pp. 117111-117111
Closed Access | Times Cited: 81
Discovery of novel benzenesulfonamides incorporating 1,2,3-triazole scaffold as carbonic anhydrase I, II, IX, and XII inhibitors
Aida Buza, Cüneyt Türkeş, Mustafa Arslan, et al.
International Journal of Biological Macromolecules (2023) Vol. 239, pp. 124232-124232
Closed Access | Times Cited: 68
Aida Buza, Cüneyt Türkeş, Mustafa Arslan, et al.
International Journal of Biological Macromolecules (2023) Vol. 239, pp. 124232-124232
Closed Access | Times Cited: 68
A simple yet multifaceted 90 years old, evergreen enzyme: Carbonic anhydrase, its inhibition and activation
Claudiu T. Supuran
Bioorganic & Medicinal Chemistry Letters (2023) Vol. 93, pp. 129411-129411
Closed Access | Times Cited: 63
Claudiu T. Supuran
Bioorganic & Medicinal Chemistry Letters (2023) Vol. 93, pp. 129411-129411
Closed Access | Times Cited: 63
Ligand based pharmacophore modelling and integrated computational approaches in the quest for small molecule inhibitors against hCA IX
Venkatesan Saravanan, Bharath Kumar Chagaleti, Shakthi Devi Packiapalavesam, et al.
RSC Advances (2024) Vol. 14, Iss. 5, pp. 3346-3358
Open Access | Times Cited: 29
Venkatesan Saravanan, Bharath Kumar Chagaleti, Shakthi Devi Packiapalavesam, et al.
RSC Advances (2024) Vol. 14, Iss. 5, pp. 3346-3358
Open Access | Times Cited: 29
Dynamics of small molecule-enzyme interactions: Novel benzenesulfonamides as multi-target agents endowed with inhibitory effects against some metabolic enzymes
Özcan Güleç, Cüneyt Türkeş, Mustafa Arslan, et al.
Archives of Biochemistry and Biophysics (2024) Vol. 759, pp. 110099-110099
Closed Access | Times Cited: 16
Özcan Güleç, Cüneyt Türkeş, Mustafa Arslan, et al.
Archives of Biochemistry and Biophysics (2024) Vol. 759, pp. 110099-110099
Closed Access | Times Cited: 16
Unprecedented carbonic anhydrase inhibition mechanism: Targeting histidine 64 side chain through a halogen bond
Roberto Paciotti, Simone Carradori, Andrea Angeli, et al.
Archiv der Pharmazie (2025) Vol. 358, Iss. 1
Open Access | Times Cited: 2
Roberto Paciotti, Simone Carradori, Andrea Angeli, et al.
Archiv der Pharmazie (2025) Vol. 358, Iss. 1
Open Access | Times Cited: 2
Metal–ligand interactions in drug design
Laura Riccardi, Vito Genna, Marco De Vivo
Nature Reviews Chemistry (2018) Vol. 2, Iss. 7, pp. 100-112
Closed Access | Times Cited: 152
Laura Riccardi, Vito Genna, Marco De Vivo
Nature Reviews Chemistry (2018) Vol. 2, Iss. 7, pp. 100-112
Closed Access | Times Cited: 152
Synthesis of diaryl ethers with acetylcholinesterase, butyrylcholinesterase and carbonic anhydrase inhibitory actions
Fadime Özbey, Parham Taslımı, İlhami Gülçın, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2016) Vol. 31, Iss. sup2, pp. 79-85
Open Access | Times Cited: 141
Fadime Özbey, Parham Taslımı, İlhami Gülçın, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2016) Vol. 31, Iss. sup2, pp. 79-85
Open Access | Times Cited: 141
Synthesis of 4,5-disubstituted-2-thioxo-1,2,3,4-tetrahydropyrimidines and investigation of their acetylcholinesterase, butyrylcholinesterase, carbonic anhydrase I/II inhibitory and antioxidant activities
Emin Garibov, Parham Taslımı, Afsun Sujayev, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2016) Vol. 31, Iss. sup3, pp. 1-9
Open Access | Times Cited: 140
Emin Garibov, Parham Taslımı, Afsun Sujayev, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2016) Vol. 31, Iss. sup3, pp. 1-9
Open Access | Times Cited: 140